Jenburkt Pharmaceuticals Ltd.

Web: jenburkt.com NSE: JENBURPH BSE: 524731 SECTOR: Healthcare - Pharmaceuticals & Biotechnology | Add Note | View Notes

890 31(-3%)

Near 52W Low of 864

Volume

2k as on 18, Sep

Open

1,203

High

1,222

Low

1,197

921

VWAP

983

52 Week High

1,074

52 Week Low

864

Viand Research Rating

Quality Score

28/100

Growth Score

18/100

Valuation Score

50/100

Momentum Score

0/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

393

No. of Shares

0.44

P/E

17.93

P/B

3.75

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

20.91

ROCE

Profit Growth

Listing Date

Rank/Sector Rank

#2112/#145

Promoter Holding

46.62%

FII Holding

DII Holding

0.12%

Price Chart

Price Performance

1 Week2%

1 Month6%

3 Months6%

6 Months6%

1 Year6%

YTD6%

Moving Average

5 Day SMA987

10 Day SMA1,011

20 Day SMA1,026

30 Day SMA0

50 Day SMA0

61 Day SMA0

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	1,038	993	1,024	1,037
Resistance 2	1,024	990	1,011	1,023
Resistance 1	1,004	987	1,003	1,002
Pivot Point	989	983	989	989
Support 1	969	980	976	968
Support 2	955	977	968	954
Support 3	934	974	955	933

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,18,698	1745	0%	5%	4%	4%	37	55.5	0.07	11509
2	DIVISLAB	2,43,966	9190	2%	0%	45%	38%	69	55.5	0	2568
3	TORNTPHARM	1,73,208	4554	2%	5%	10%	28%	72	55.5	1.79	2138
4	ZYDUSLIFE	1,11,451	1117	0%	1%	20%	12%	20	55.5	0.31	3560
5	APOLLOHOSP	1,09,276	7600	2%	9%	4%	1%	58	55.5	0.9	2003
6	LAURUSLABS	1,08,738	2012	1%	8%	83%	124%	0	55.5	0.48	890
7	CIPLA	1,06,154	1314	2%	2%	8%	19%	22	55.5	0.02	3862
8	DRREDDY	1,03,873	1244	3%	8%	1%	4%	20	55.5	0.2	4158
9	MANKIND	94,401	2286	4%	1%	8%	7%	49	55.5	0.39	1938
10	AUROPHARMA	90,841	1579	2%	1%	20%	52%	0	55.5	0.19	2415
Load More

Shareholding Pattern (%)

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021
Promoters	(0.01) 46.62%	(0.01) 46.64%	(0.01) 46.65%	(0.01) 46.66%	(0.01) 46.67%	(0.01) 46.68%	(0.01) 46.69%	(0.01) 46.71%	(-0.51) 46.71%	(-0.21) 47.23%	(0.01) 47.39%	(-0.11) 47.42%	(0.01) 47.56%	(1.61) 47.56%	(0.21) 45.96%	(0.01) 45.74%	(0.01) 45.73%	(0.01) 45.73%	(0.01) 45.73%
FIIs	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(-1.41) 0.00%	(-0.41) 1.38%	(-0.91) 1.79%	(-0.81) 2.70%	(-1.31) 3.49%	(0.41) 4.79%	(0.01) 4.37%	(0.01) 4.37%	(0.01) 4.37%
DIIs	(0.01) 0.12%	(0.01) 0.12%	(0.01) 0.12%	(0.01) 0.12%	(0.01) 0.12%	(0.01) 0.12%	(0.11) 0.12%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%
Public	53.27%	53.24%	53.24%	53.22%	53.21%	53.20%	53.20%	53.28%	53.29%	52.78%	52.63%	51.21%	50.65%	49.73%	50.52%	49.48%	49.90%	49.90%	49.90%
No. of Shareholders	7,103	6,999	7,163	6,855	6,712	6,987	6,901	6,628	6,419	6,316	6,021	5,872	5,741	5,611	5,784	5,896	6,016	6,053	6,116

Quarterly Results

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Sales	35.51	44.63	43.02	45.56	35.53	41.05	36.89	41.22	32.54	38.84	35.66	38.29	29.18	35	34.57	36	31.13	28.29	33	35.51
Sales Growth % (YoY)	-0.1%	8.7%	16.6%	10.5%	9.2%	5.7%	3.4%	7.6%	11.5%	10.3%	3.2%	6.8%	-6.3%	-	4.8%	1%	14.5%	-4.3%	3.7%	16.5%
Sales Growth % (QoQ)	-20.4%	3.7%	-5.6%	28.2%	-13.4%	11.3%	-10.5%	26.7%	-16.2%	8.9%	-6.9%	31.2%	-16.6%	1.2%	-4%	15.6%	10%	-14.3%	-7.1%	-
Expenses	29.48	30.38	35.59	32.45	26.58	30.19	28.07	29.79	23.26	28.99	28.47	29.19	22.22	28	27.59	27	23.85	23.64	26.03	25.24
Operating Profit	6.03	14.25	7.43	13.11	8.95	10.86	8.82	11.43	9.28	9.85	7.19	9.1	6.96	7	6.98	9	7.28	4.65	6.97	10.27
OPM %	16.98	31.93	17.27	28.78	25.19	26.46	23.91	27.73	28.52	25.36	20.16	23.77	23.85	21	20.19	24	23.39	16.44	21.12	28.92
Other Income	1.51	0.4	1.82	2.08	2.06	1.88	1.58	1.85	1.41	1.19	1.35	1.1	1.04	1	1.46	1	1.14	1.28	1.29	1.19
Interest	0.13	0.13	0.12	0.11	0.11	0.11	0.11	0.12	0.11	0.06	0.07	0.07	0.07	0	0.1	0	0.09	0.12	0.1	0.11
Depreciation	0.64	0.81	0.83	0.74	0.72	0.79	0.78	0.64	0.52	0.62	0.63	0.59	0.5	1	0.58	1	0.54	0.54	0.47	0.45
Profit before tax	6.77	13.71	8.3	14.34	10.18	11.84	9.51	12.52	10.06	10.36	7.84	9.54	7.43	8	7.76	9	7.79	5.27	7.69	10.9
Tax %	13	20.86	28.55	29.08	23.48	27.87	31.65	23.32	26.34	23.94	31.12	23.27	27.73	21	29.9	26	23.62	34.54	18.99	26.88
Net Profit	5.89	10.85	5.93	10.16	7.79	8.54	6.51	9.6	7.42	7.88	5.4	7.32	5.37	6	5.43	7	5.95	3.45	6.23	7.97
Net Profit Growth % (QoQ)	-45.7%	83%	-41.6%	30.4%	-8.8%	31.2%	-32.2%	29.4%	-5.8%	45.9%	-26.2%	36.3%	-10.5%	10.5%	-22.4%	17.6%	72.5%	-44.6%	-21.8%	-
Net Profit Growth % (YoY)	-24.4%	27%	-8.9%	5.8%	5%	8.4%	20.6%	31.1%	38.2%	31.3%	-0.6%	4.6%	-9.7%	73.9%	-12.8%	-12.2%	-	-	-	-
TTM Net Profit	32.83	34.73	32.42	33	32.44	32.07	31.41	30.3	28.02	25.97	24.09	24.12	23.8	24.38	21.83	22.63	23.6	17.65	14.2	0
EPS in Rs	13.35	24.58	13.44	23.02	17.65	19.35	14.75	21.75	16.81	17.86	12.24	16.59	12.17	14.39	11.83	14.97	12.96	7.52	13.57	17.37

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Sales	169	152	142	137	124	109	119	123	115	103	94	85	76	69
Sales Growth %	11.2%	6.8%	3.8%	10.3%	13.4%	-8.1%	-3.1%	7%	11%	10.4%	9.8%	11.8%	9.9%	15.9%
Expenses	125	111	109	106	97	89	99	98	91	84	77	70	65	59
Operating Profit	44	40	33	30	27	20	20	25	24	20	16	15	12	10
OPM %	26	27	23	22	22	18	17	20	21	19	18	18	15	15
Other Income	6	7	5	5	5	4	4	3	3	3	3	2	2	1
Interest	0	0	0	0	0	0	1	0	0	0	0	0	1	1
Depreciation	3	3	2	2	2	2	2	1	2	2	2	3	2	1
Profit before tax	47	44	35	33	30	22	21	27	25	20	17	14	10	9
Tax %	25	27	26	25	25	24	30	26	32	34	36	33	27	30
Net Profit	35	32	26	25	22	16	15	20	17	14	11	10	8	6
Net Profit Growth %	9.4%	23.1%	4%	13.6%	37.5%	6.7%	-25%	17.6%	21.4%	27.3%	10%	25%	33.3%	-
EPS in Rs	78.72	72.64	58.87	55.76	48.59	35.95	32.4	43.14	37.5	29.06	23.19	20.76	16.15	13.38
Dividend Payout %	26	25	26	26	25	28	25	24	24	28	31	30	32	31

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Cash from Operating Activity	27	28	8	17	9	19	15	13	16	10	8	9	11	5
Cash from Investing Activity	-19	-17	-1	3	-1	-19	-3	-11	1	-10	0	1	0	-1
Cash from Financing Activity	-9	-8	-7	-21	-6	-1	-11	-2	-18	1	-5	1	-7	0
Net Cash Flow	-2	3	0	-1	3	0	1	0	-1	1	2	11	5	3

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Equity Capital	4	4	4	4	4	4	5	5	5	5	5	5	5	5	5	5
Reserves	193	178	167	153	141	118	113	94	75	73	57	50	36	29	23	18
Borrowings	2	2	4	2	0	3	7	5	3	7	0	6	5	7	2	5
Other Liabilities	26	24	19	22	19	16	18	17	21	18	16	16	12	21	15	22
Total Liabilities	225	209	195	181	164	141	143	120	104	103	77	76	58	61	44	49
Fixed Assets	19	14	15	14	10	10	11	11	12	10	10	11	12	12	14	14
CWIP	46	52	40	0	1	1	0	0	0	1	0	0	0	0	0	0
Investments	27	27	21	32	17	11	8	7	4	5	5	2	1	0	0	0
Other Assets	132	116	120	135	136	119	123	103	88	87	62	64	45	49	30	34
Total Assets	225	209	195	181	164	141	143	120	104	103	77	76	58	61	44	49

Delivery

Delivery Data: JENBURPH

#	Date	864 24% 1074	Value (Cr)	Q/T 40	Del 71	Del 0
1	21-Oct	892	0	10	83	0
2	19-Oct	921	0	8	75	0
3	16-Oct	923	0	6	62	0
4	15-Oct	916	0	8	80	0
5	14-Oct	920	0	5	77	0
6	13-Oct	919	0	9	91	0
7	12-Oct	924	0	16	80	0
8	9-Oct	947	0	10	68	0
9	8-Oct	954	2	12	43	1
10	7-Oct	891	0	16	97	0
11	6-Oct	906	0	10	86	0
12	5-Oct	900	0	12	91	0
13	1-Oct	915	0	11	72	0
14	30-Sep	915	0	19	93	0
15	29-Sep	924	0	18	80	0
16	28-Sep	926	0	9	78	0
17	25-Sep	948	0	8	81	0
18	24-Sep	954	0	13	89	0
19	23-Sep	952	0	8	80	0
20	22-Sep	957	0	7	70	0
21	21-Sep	980	0	10	78	0
22	18-Sep	980	0	27	92	0
23	17-Sep	983	0	28	91	0
24	16-Sep	992	0	7	83	0
25	15-Sep	974	0	17	91	0
26	11-Sep	1004	0	12	95	0
27	10-Sep	1027	0	15	83	0
28	9-Sep	1024	0	15	80	0
29	8-Sep	1040	0	8	96	0
30	7-Sep	1043	0	8	85	0
31	4-Sep	1039	0	11	90	0
32	3-Sep	1032	0	74	98	0
33	2-Sep	1044	0	15	84	0
34	1-Sep	1048	0	62	100	0
35	31-Aug	1051	0	20	80	0
36	28-Aug	1048	0	9	58	0
37	27-Aug	1033	0	13	86	0
38	26-Aug	1050	0	13	99	0
39	25-Aug	1046	0	50	98	0
40	24-Aug	1044	0	19	82	0
41	21-Aug	1028	0	13	89	0
42	20-Aug	1046	0	20	90	0
43	19-Aug	1054	0	12	75	0
44	18-Aug	1047	0	7	82	0
45	17-Aug	1045	0	18	75	0

Daily Market Cap

Date	Total Market Cap	Change	Chg %
21-Oct	393c	7c	1.67
19-Oct	400c	7c	1.63
17-Oct	406c	0	0
16-Oct	406c	2c	0.44
15-Oct	404c	5c	1.32
14-Oct	410c	5c	1.12
13-Oct	405c	3c	0.74
12-Oct	408c	9c	2.15
09-Oct	417c	5c	1.26
08-Oct	412c	1c	0.26
01-Oct	413c	7c	1.75
29-Sep	406c	2c	0.36
28-Sep	407c	19c	4.44
25-Sep	426c	4c	0.97
24-Sep	422c	1c	0.33
22-Sep	424c	20c	4.46
17-Sep	443c	15c	3.20
10-Sep	458c	8c	1.66
07-Sep	466c	0	0

Stock Checklist

Price is above from 52 week high low average: 12%

Stock is trading above all short term SMAs: NO

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: NO

Promoters are buying the stock: NO

Mutual Fund Holdings

No mutual fund holding data available.

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements

Corporate Announcements

NseIndia | Trendlyne | Screener | TradingView